University of California San Francisco
Give to UCSF
Behavioral weight-loss programs can be an effective way to reduce urinary incontinence in women who are overweight or obese, according to a study led by researchers at the University of California, San Francisco.
The UCSF Center for Translational and Policy Research on Personalized Medicine is sponsoring a symposium on February 5 to address the impact of health reform and related issues in the field.
UCSF’s Victor I. Reus, who is considered an expert in training the next generation of mental health professionals, will receive a national award in October.
In African American women with breast cancer, high blood pressure lessens the chances of survival compared with white women, a new UCSF study finds.
Two HIV prevention interventions developed by UCSF researchers have been selected as additions to the Centers for Disease Control and Prevention’s 2008 Compendium of Evidence-based HIV Prevention Interventions.
The deadline to apply for fall 2009 entry into the Master’s Program in Global Health Sciences is Jan. 30.
Members of the community can nominate a colleague for the Milton and Helen Pearl Award for Outstanding Service.
Scientists have discovered a novel way by which a much-studied cancer-promoting gene accelerates the disease. The finding suggests a new strategy to halt cancer’s progress.
Children with newly diagnosed cases of inflammatory bowel disease have higher concentrations of folate in their blood than individuals without IBD, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley. The findings bring into question the previously held theory that patients with IBD are prone to folate – also known as folic acid – deficiency.
A partnership between UCSF and a San Francisco high school earned the team certificates of honor from the city Board of Supervisors and the California Legislature.
The rate of sudden deaths increased six-fold in the first year that California law enforcement agencies deployed the use of stun guns, according to a UCSF study. Findings also showed a two-fold increase in the rate of firearm-related deaths during the same time period.
With support from the Fogarty International Center, the UCSF School of Nursing is examining the impact of stigma as it relates to nurses who care for HIV patients in developing countries.
Faculty are invited to submit an application for the next round of funding by March 2 in the Resource Allocation Program.
Scientists at UCSF have discovered an abnormality in a patient’s immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection.
Drug side effects have been sidelining already-approved drugs. New inventions by Laurence Tecott, MD, PhD, and Evan Goulding, MD, PhD, allow monitoring of complex mouse behaviors and may yield early warnings of possible pharmaceutical side effects. Big Pharma and biotech drug development should benefit as a result.
MicroRNA inhibitors of genes reveal their targets in a UCSF Kaposi’s sarcoma study. Howard Hughes Medical Institute investigator Don Ganem leads efforts to find guiding principles that will point to the targets of microRNA in health and disease.
A 3-year-old who lost his hearing in a US missile attack receives a cochlear implant at UCSF after a massive fundraising effort and outpouring of support his father calls “beyond my imagination.”
Faculty who are going to the inauguration of Barack Obama on Jan. 20 are feeling optimistic about the future.
A 3-year-old Iraqi boy will undergo surgery at UCSF Medical Center today (Friday, January 16), to restore his hearing, which was destroyed in June 2007 when a U.S. explosive device hit his neighbor’s house.
The pharmaceutical company Parke-Davis employed “the systematic use of deception and misinformation” in order to manipulate physicians into prescribing the drug gabapentin for so-called off-label uses, write two San Francisco VA Medical Center physicians in the New England Journal of Medicine.
Chancellor Mike Bishop, who will step down from the top post in June, delivered his final annual report on Tuesday, citing many accomplishments over the past year and thanking 18,000 employees for their service to UCSF.
A team of UCSF researchers has discovered a protein duo that regulates the formation of endothelial cells – a breakthrough that has significant scientific and therapeutic implications.
Acting on the recommendation of University of California President Mark G. Yudof, the UC Board of Regents today (Jan. 14) approved plans curtailing undergraduate enrollment growth, and freezing the salaries of top administrators and significantly restricting compensation for a large group of senior leadership.
Application forms will be accepted through March 2 for the position of staff advisor-designate to the UC Board of Regents.